A detailed history of Robeco Institutional Asset Management B.V. transactions in Incyte Corp stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 1,265,966 shares of INCY stock, worth $89.9 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,265,966
Previous 1,195,370 5.91%
Holding current value
$89.9 Million
Previous $72.5 Million 15.48%
% of portfolio
0.17%
Previous 0.16%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$57.33 - $68.61 $4.05 Million - $4.84 Million
70,596 Added 5.91%
1,265,966 $83.7 Million
Q2 2024

Jul 22, 2024

BUY
$51.18 - $63.75 $2.23 Million - $2.78 Million
43,652 Added 3.79%
1,195,370 $72.5 Million
Q1 2024

Apr 24, 2024

BUY
$56.55 - $66.59 $4.86 Million - $5.72 Million
85,941 Added 8.06%
1,151,718 $65.6 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $25 Million - $30.8 Million
479,124 Added 81.67%
1,065,777 $66.9 Million
Q4 2023

Feb 08, 2024

SELL
$52.16 - $64.19 $15 Million - $18.4 Million
-287,287 Reduced 32.87%
586,653 $1.07 Billion
Q3 2023

Oct 23, 2023

BUY
$57.77 - $65.93 $12.2 Million - $13.9 Million
210,820 Added 31.79%
873,940 $50.5 Million
Q2 2023

Jul 24, 2023

BUY
$60.95 - $75.51 $5.25 Million - $6.5 Million
86,116 Added 14.92%
663,120 $41.3 Million
Q1 2023

May 03, 2023

BUY
$70.23 - $86.01 $16.5 Million - $20.2 Million
234,913 Added 68.67%
577,004 $41.7 Million
Q4 2022

Feb 06, 2023

BUY
$67.18 - $84.11 $1.49 Million - $1.87 Million
22,241 Added 6.95%
342,091 $27.5 Million
Q3 2022

Dec 01, 2022

BUY
$66.18 - $82.86 $18.1 Million - $22.6 Million
273,113 Added 584.36%
319,850 $21.3 Million
Q3 2022

Oct 26, 2022

BUY
$66.18 - $82.86 $18.1 Million - $22.6 Million
273,113 Added 584.36%
319,850 $21.3 Million
Q2 2022

Dec 01, 2022

BUY
$66.18 - $83.18 $943,991 - $1.19 Million
14,264 Added 43.93%
46,737 $3.55 Million
Q2 2022

Jul 27, 2022

BUY
$66.18 - $83.18 $943,991 - $1.19 Million
14,264 Added 43.93%
46,737 $3.55 Million
Q1 2022

Dec 01, 2022

BUY
$66.02 - $79.71 $2,640 - $3,188
40 Added 0.12%
32,473 $2.58 Million
Q1 2022

Apr 26, 2022

BUY
$66.02 - $79.71 $2,640 - $3,188
40 Added 0.12%
32,473 $2.58 Million
Q4 2021

Dec 01, 2022

BUY
$63.34 - $74.11 $99,380 - $116,278
1,569 Added 5.08%
32,433 $2.38 Million
Q4 2021

Jan 31, 2022

BUY
$63.34 - $74.11 $99,380 - $116,278
1,569 Added 5.08%
32,433 $2.38 Million
Q3 2021

Dec 01, 2022

SELL
$68.67 - $84.02 $156,773 - $191,817
-2,283 Reduced 6.89%
30,864 $2.12 Million
Q3 2021

Oct 20, 2021

SELL
$68.67 - $84.02 $156,773 - $191,817
-2,283 Reduced 6.89%
30,864 $2.12 Million
Q2 2021

Dec 01, 2022

SELL
$79.87 - $87.53 $7.39 Million - $8.1 Million
-92,550 Reduced 73.63%
33,147 $2.79 Million
Q2 2021

Jul 28, 2021

SELL
$79.87 - $87.53 $7.39 Million - $8.1 Million
-92,550 Reduced 73.63%
33,147 $2.79 Million
Q1 2021

Dec 01, 2022

SELL
$76.02 - $100.5 $14.8 Million - $19.5 Million
-194,153 Reduced 60.7%
125,697 $10.2 Million
Q1 2021

Apr 23, 2021

SELL
$76.02 - $100.5 $7.23 Million - $9.55 Million
-95,072 Reduced 43.06%
125,697 $10.2 Million
Q4 2020

Dec 01, 2022

SELL
$80.74 - $97.7 $8 Million - $9.68 Million
-99,081 Reduced 30.98%
220,769 $19.2 Million
Q4 2020

Jan 28, 2021

SELL
$80.74 - $97.7 $2.94 Million - $3.56 Million
-36,391 Reduced 14.15%
220,769 $19.2 Million
Q3 2020

Oct 29, 2020

BUY
$85.07 - $109.69 $40,493 - $52,212
476 Added 0.19%
257,160 $23.1 Million
Q2 2020

Jul 20, 2020

BUY
$74.18 - $108.93 $1.96 Million - $2.88 Million
26,406 Added 11.47%
256,684 $26.7 Million
Q1 2020

Apr 30, 2020

BUY
$63.18 - $85.97 $2.32 Million - $3.16 Million
36,777 Added 19.01%
230,278 $16.9 Million
Q4 2019

Feb 06, 2020

BUY
$73.04 - $95.72 $6.49 Million - $8.5 Million
88,809 Added 84.83%
193,501 $16.9 Million
Q3 2019

Oct 17, 2019

BUY
$72.82 - $86.52 $4.26 Million - $5.06 Million
58,448 Added 126.39%
104,692 $7.77 Million
Q2 2019

Jul 19, 2019

BUY
$73.52 - $88.7 $3.13 Million - $3.78 Million
42,610 Added 1172.54%
46,244 $3.93 Million
Q2 2018

Aug 03, 2018

SELL
$60.85 - $83.98 $212,975 - $293,930
-3,500 Reduced 49.06%
3,634 $244,000
Q4 2017

Jan 25, 2018

BUY
$93.56 - $116.6 $284,328 - $354,347
3,039 Added 74.21%
7,134 $675,000
Q3 2017

Oct 17, 2017

SELL
$109.15 - $138.27 $292,303 - $370,287
-2,678 Reduced 39.54%
4,095 $478,000
Q2 2017

Aug 08, 2017

SELL
N/A
-426 Reduced 5.92%
6,773 $854,000
Q1 2017

Jan 19, 2021

BUY
N/A
7,199
7,199 $962,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.